相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。γ-Carboxylation of osteocalcin and insulin resistance in older men and women
M. Kyla Shea et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects
You-Cheol Hwang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men
Jenny M. Kindblom et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
Ippei Kanazawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Relationship between osteocalcin and glucose metabolism in postmenopausal women
Jee-Aee Im et al.
CLINICA CHIMICA ACTA (2008)
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Evanthia Diamanti-Kandarakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome
Hector F. Escobar-Morreale et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells
L. Schurman et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
Angela Cassese et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: A randomized, placebo-controlled trial
Dorte Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome
E. Diamanti-Kandarakis et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
Mathieu Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reciprocal regulation of bone and energy metabolism
Na Kyung Lee et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
Damaris Vega et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome
D Panidis et al.
CLINICAL CHEMISTRY (2005)
beta-cell function: A key pathological determinant in polycystic ovary syndrome
MO Goodarzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Impaired gamma carboxylation of osteocalcin in elderly women with type II diabetes mellitus: relationship between increase in undercarboxylated osteocalcin levels and low bone mineral density
T Horiuchi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2004)
Bone matrix proteins: their function, regulation, and relationship to osteoporosis
MF Young
OSTEOPOROSIS INTERNATIONAL (2003)
分享论文
